Regeneron Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US75886F1075

SecurityREGN / Regeneron Pharmaceuticals, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership30,161 shares
Latest Disclosed Value $ 16,912,781
Wolverine Trading, Llc ownership in REGN / Regeneron Pharmaceuticals, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 30,161 shares of Regeneron Pharmaceuticals, Inc. (US:REGN) valued at $16,958,625 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 19,578 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 54.06% during the quarter. The current value of the position is $18,668,151 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 81,900 of underlying shares valued at $45,925,425 USD and put options representing 65,100 of underlying shares valued at $36,504,825 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 30,161 10,583 54.06 16,913 65.80 0.0122
2025-08-18 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 19,578 4,588 30.61 10,200 6.76 0.0103
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 14,990 1,802 13.66 9,554 3.12 0.0112
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 13,188 11,552 706.11 9,266 443.40 0.0087
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,636 1,012 162.18 1,706 160.31 0.0018
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 624 -4,513 -87.85 656 -86.75 0.0007
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,137 2,685 109.50 4,944 129.63 0.0050
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,452 -2,083 -45.93 2,154 -42.31 0.0023
2023-11-15 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,535 4,535 3,732 0.0038
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -55,200 -100.00 0 -100.00
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 55,200 54,753 12,248.99 39,826 12,788.67 0.0604
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 447 447 309 0.0005
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -3,898 -100.00 0 -100.00
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,898 -1,083 -21.74 2,699 -15.66 0.0035
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,981 -4,370 -46.73 3,200 -43.59 0.0038
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 9,351 5,121 121.06 5,673 145.69 0.0064
2021-08-06 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,230 -7,342 -63.45 2,309 -57.61 0.0036
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 11,572 10,776 1,353.77 5,447 1,329.66 0.0082
2021-02-12 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 796 796 381 0.0006
2020-05-11 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -5,833 -100.00 0 -100.00
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,833 2,173 59.37 2,180 117.78 0.0053
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,660 3,660 1,001 0.0029
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -3,482 -100.00 0 -100.00
2019-02-13 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,482 2,336 203.84 1,263 172.79 0.0036
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,146 1,146 463 0.0010
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -4,049 -100.00 0 -100.00
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,049 -2,464 -37.83 1,522 -47.73 0.0055
2017-11-15 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,513 6,513 2,912 0.0111
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -426 -100.00 0 -100.00
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 426 426 148 0.0008
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM Call 81,900 17.00 45,925 25.93 n/a n/a n/a
2025-08-18 2025-06-30 13F REGENERON PHARMACEUTICALS COM Call 70,000 32.08 36,470 7.96 n/a n/a n/a
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM Call 53,000 9.05 33,780 -1.07 n/a n/a n/a
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM Call 48,600 24.62 34,146 -16.03 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Call 39,000 54.76 40,665 53.54 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM Call 25,200 34.04 26,486 46.37 n/a n/a n/a
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM Call 18,800 -16.44 18,095 -8.44 n/a n/a n/a
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM Call 22,500 15.98 19,762 23.78 n/a n/a n/a
2023-11-15 2023-09-30 13F REGENERON PHARMACEUTICALS COM Call 19,400 -54.67 15,965 -47.34 n/a n/a n/a
2023-08-23 2023-06-30 13F REGENERON PHARMACEUTICALS COM Call 42,800 30,320 n/a n/a n/a
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Call 23,200 0.00 16,739 4.29 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM Call 23,200 19.59 16,050 38.43 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Call 19,400 30.20 11,594 12.39 n/a n/a n/a
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM Call 14,900 -52.09 10,316 -48.37 n/a n/a n/a
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM Call 31,100 -23.21 19,982 -18.68 n/a n/a n/a
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS COM Call 40,500 2.02 24,571 13.36 n/a n/a n/a
2021-08-06 2021-06-30 13F REGENERON PHARMACEUTICALS COM Call 39,700 30.16 21,675 50.99 n/a n/a n/a
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM Call 30,500 -67.24 14,355 -67.76 n/a n/a n/a
2021-02-12 2020-12-31 13F REGENERON PHARMACEUTICALS COM Call 93,100 68.66 44,530 40.64 n/a n/a n/a
2020-11-13 2020-09-30 13F REGENERON PHARMACEUTICALS COM Call 55,200 -10.53 31,663 -15.99 n/a n/a n/a
2020-08-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM Call 61,700 37,691 n/a n/a n/a
2020-05-11 2020-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS COM Call 98,300 -5.12 36,735 29.67 n/a n/a n/a
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM Call 103,600 28,330 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F REGENERON PHARMACEUTICALS COM Call 61,600 12.00 22,337 0.52 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM Call 55,000 -5.01 22,222 11.46 n/a n/a n/a
2018-08-13 2018-06-30 13F REGENERON PHARMACEUTICALS COM Call 57,900 0.00 19,938 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Call 57,900 -31.40 19,938 -37.17 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM Call 84,400 11.49 31,731 -6.25 n/a n/a n/a
2017-11-15 2017-09-30 13F REGENERON PHARMACEUTICALS COM Call 75,700 33,847 n/a n/a n/a
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICALS COM Call 61,900 95.89 23,905 86.16 n/a n/a n/a
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM Call 31,600 -14.36 12,841 0.04 n/a n/a n/a
2016-08-17 2016-06-30 13F/A REGENERON PHARMACEUTICALS COM Call 36,900 12,836 n/a n/a n/a
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM Call 369 12,836 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM Put 65,100 3.01 36,505 10.86 n/a n/a n/a
2025-08-18 2025-06-30 13F REGENERON PHARMACEUTICALS COM Put 63,200 15.96 32,927 -5.21 n/a n/a n/a
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM Put 54,500 21.11 34,736 9.87 n/a n/a n/a
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM Put 45,000 27.84 31,617 -13.86 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Put 35,200 19.73 36,703 18.78 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM Put 29,400 -23.24 30,900 -16.18 n/a n/a n/a
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM Put 38,300 -22.63 36,863 -15.21 n/a n/a n/a
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM Put 49,500 81.32 43,475 93.51 n/a n/a n/a
2023-11-15 2023-09-30 13F REGENERON PHARMACEUTICALS COM Put 27,300 7.06 22,467 24.37 n/a n/a n/a
2023-08-23 2023-06-30 13F REGENERON PHARMACEUTICALS COM Put 25,500 18,065 n/a n/a n/a
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Put 89,100 421.05 64,285 443.41 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM Put 17,100 98.84 11,830 130.16 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Put 8,600 -20.37 5,140 -31.27 n/a n/a n/a
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM Put 10,800 -73.66 7,478 -71.61 n/a n/a n/a
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM Put 41,000 23.49 26,343 30.79 n/a n/a n/a
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS COM Put 33,200 -17.21 20,142 -8.00 n/a n/a n/a
2021-08-06 2021-06-30 13F REGENERON PHARMACEUTICALS COM Put 40,100 31.05 21,894 52.01 n/a n/a n/a
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM Put 30,600 -47.60 14,403 -48.44 n/a n/a n/a
2021-02-12 2020-12-31 13F REGENERON PHARMACEUTICALS COM Put 58,400 37.41 27,933 14.58 n/a n/a n/a
2020-11-13 2020-09-30 13F REGENERON PHARMACEUTICALS COM Put 42,500 -4.49 24,378 -10.32 n/a n/a n/a
2020-08-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM Put 44,500 27,184 n/a n/a n/a
2020-05-11 2020-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS COM Put 89,600 16.97 33,484 59.85 n/a n/a n/a
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM Put 76,600 20,947 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F REGENERON PHARMACEUTICALS COM Put 64,800 6.75 23,498 -4.19 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM Put 60,700 -4.56 24,525 11.98 n/a n/a n/a
2018-08-13 2018-06-30 13F REGENERON PHARMACEUTICALS COM Put 63,600 0.00 21,901 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Put 63,600 -21.96 21,901 -28.52 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM Put 81,500 -15.46 30,641 -28.91 n/a n/a n/a
2017-11-15 2017-09-30 13F REGENERON PHARMACEUTICALS COM Put 96,400 43,102 n/a n/a n/a
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICALS COM Put 64,100 113.67 24,754 103.05 n/a n/a n/a
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM Put 30,000 -27.01 12,191 -14.73 n/a n/a n/a
2016-08-17 2016-06-30 13F/A REGENERON PHARMACEUTICALS COM Put 41,100 14,297 n/a n/a n/a
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM Put 411 14,297 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.